Australia
Australia's IFM: The customized approach
IFM Investors has moved from fund-of-funds through co-investment to a direct approach designed to meet its superannuation fund clients’ concerns about access, cost, and transparency. Is it working?
Specialization: Buying better
Should the next-generation Australian private equity firm be doing more to differentiate itself from the competition - in the eyes of potential investees as well as investors?
Australia distress: The luxury of time
Two pieces of legislation – one enacted and the other pending – are expected to facilitate corporate restructuring in Australia. It remains to be seen how turnaround investors take advantage of this
Australia's PEP launches secure assets fund
Pacific Equity Partners (PEP) has launched an Australia and New Zealand-focused secure assets fund intended to invest in companies that generate annuity income but also offer opportunities for traditional private equity-style operational improvement.
Q&A: Pacific Equity Partners' Tim Sims
Tim Sims, co-founder and managing director of Pacific Equity Partners, discusses competition in Australian private equity, approaches to co-investment, succession planning, and his firm’s secure assets fund
Australia consumer: Attitude adjustment
Demographic shifts are prompting Australian GPs to reevaluate domestic consumer plays with an eye toward processes rather than goods. Overseas markets are an increasingly important part of the equation
Thoma Bravo to buy Australian software player Nintex
Nintex, a workflow management software provider founded in Australia but now with a global footprint, has agreed to sell a majority stake to US-based middle market GP Thoma Bravo.
NAB Ventures backs $4.6m round for Australia's ActivePipe
NAB Ventures, a unit of National Australia Bank (NAB), has invested A$5.9 million ($4.6 million) in ActivePipe, a Melbourne-based software supplier for the real estate industry.
Allergan to acquire Australia's VC-backed Elastagen
Allergan, a US-listed pharmaceutical company and the owner of Botox cosmetic injectable products, has agreed to acquire Elastagen, an Australian skin treatment developer backed by a number of VCs, in a deal worth up to $260 million.
PEP to buy Australia's LifeHealthcare
Pacific Equity Partners (PEP) has agreed to buy listed Australian medical devices manufacturer LifeHealthcare for an enterprise valuation of approximately A$211 million ($166 million).
Proterra buys Australia agriculture assets
One Tree Agriculture, an Australia-based agriculture investor owned by Proterra Investment Partners, has purchased three farm properties in New South Wales.
Blackstone bids for Australian auto panel repair business
The Blackstone Group has offered to buy the panel repair business of Australia-listed automotive aftercare services and accessories provider AMA Group for an enterprise valuation of A$530 million ($427 million).
Deal focus: Permira takes the I-Med baton from EQT
Permira's first Australia investment provides EQT Partners with an exit from medical imaging service I-Med Radiology Network
Permira to buy Australia's I-Med from EQT
Permira is set to make its first investment in Australia after reaching an agreement with EQT Partners to acquire I-Med Radiology Network.
Australian superannuation reform: Efficiency drive
With proposed changes to Australia’s superannuation system emphasizing performance rather than just cost, more money could be directed into expensive yet high-performing asset classes like private equity
Deal focus: Quadrant finds a taste for candy
Leveraging a relationship established through an investment in VIP Petfoods, Quadrant Private Equity secured a buyout of Australian candy maker Darrell Lea
BGH sets $2b hard cap for debut Australia fund
BGH Capital, the Australia and New Zealand-focused private equity firm set up by Ben Gray, formerly co-head of TPG Capital in Asia, has set a hard cap of A$2.5 billion ($2 billion) for its debut fund.
Crescent buys Australian CRO business
Crescent Capital Partners has acquired Australia-based clinical research organization (CRO) Nucleus Network from The Baker Institute, an independent research institute that focuses on heart disease and diabetes.
Australia agriculture: Fruitful endeavors
Despite their strong growth potential, Australian food crops have attracted little activity from the private equity community. Investors’ interest is restrained by the high hurdles to managing these assets
Quadrant acquires Australia's Darrell Lea
Quadrant Private Equity has acquired Darrell Lea, a candy maker based in Australia and New Zealand.
Partners Group exits Australia cancer clinic
Partners Group has sold its entire 21% stake in Australia’s Victorian Comprehensive Cancer Centre (VCCC) to AMP Capital.
Carlyle promotes Australia buyout head to partner
The Carlyle Group has promoted David Bluff, head of its buyout team in Australia and New Zealand, to partner. He was previously a managing director with the firm.
Deal focus: VCs fuel Canva’s growth designs
Australia's Canva achieves a $1 billion valuation following a $40 million round led by Sequoia Capital China
Grey Mountain buys pallet business from Australia's Brambles
Australian container supplier Brambles has agreed to sell its North American recycled pallet business to Grey Mountain Partners, a US-based mid-market GP, for an enterprise value of $115 million.